To access this element change to forms mode OFF
Grant Award View - GA30182
Engineering human dendritic cells for tolerogenic gene therapy of type 1...
GA ID:
GA30182
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
25-Oct-2018
Publish Date:
21-Dec-2018
Category:
Medical Research
Grant Term:
1-Jan-2019 to 31-Dec-2021
Value (AUD):
$831,653.00
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 17/18 1.1 Health and Medical Research
Grant Program:
Project
Grant Activity:
Engineering human dendritic cells for tolerogenic gene therapy of type 1 diabetes
Purpose:
Type 1 diabetes (T1D) afflicts more than 100,000 Australians and results from autoimmune destruction of insulin producing beta-cells. Insulin injections are required for survival, but T1D leads to substantial illness and reduced life expectancy. This project will test a newly-developed immunotherapeutic approach in a humanized mouse model of disease. Successful completion would accelerate the translation of this approach as a potential cure for T1D.
GO ID:
GO Title:
NHMRC Project Grant Scheme
Internal Reference ID:
GNT1162066
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
University of Queensland
Recipient ABN:
63 942 912 684
Grant Recipient Location
Suburb:
St Lucia
Town/City:
St Lucia
Postcode:
4072
State/Territory:
QLD
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
QLD
Postcode:
Country:
AUSTRALIA